| 1 |
32880833 | Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh. | 2020 Sep |
1 |
| 2 |
31190883 | Effect of XPC polymorphisms on the response to platinum-based chemotherapy: a meta-analysis. | 2019 |
3 |
| 3 |
28540485 | XPC Polymorphism and Risk for Lung Cancer in North Indian Patients Treated with Platinum Based Chemotherapy and Its Association with Clinical Outcomes. | 2018 Apr |
3 |
| 4 |
28878296 | Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy. | 2017 Sep 6 |
1 |
| 5 |
26213845 | eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation. | 2015 Sep 22 |
2 |
| 6 |
22821704 | Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. | 2013 Dec |
1 |
| 7 |
23621265 | DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy. | 2013 |
1 |
| 8 |
21751198 | Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer. | 2012 Feb 1 |
1 |
| 9 |
22166526 | XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer. | 2010 Dec |
1 |
| 10 |
16061005 | [Polymorphisms in nucleotide excision repair genes XPC and XPD and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer]. | 2005 Apr 13 |
3 |